Clinical Study Group News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Study Group. Real-time updates on events, politics, business and more.

Management of Clostridoides Difficile: A Focus on the Pharmacist's Role in the Care Continuum

June 16, 2023

Patient education and counseling play a critical role in preventing C. difficile recurrence, and pharmacists are uniquely positioned to provide treatment recommendations, educate patients and health care providers, optimize transitions of care, and reduce the risk of recurrent CDI.

United States Davidn Dahdal Paul Feuerstadt Infectious Diseases Society Of America Centers For Disease C Diff Centers For Disease

Source: pharmacytimes.com

Tillotts Pharma AG announces that DIFICLIRTM (fidaxomicin) is recommended for the treatment of Clostridioides difficile infection (CDI) by ESCMID

December 8, 2021

DIFICLIRTM (fidaxomicin) is now recommended as first-line CDI treatment in both European and U.S. guidelines1,2 Significantly fewer patients in the fidaxomicin group than the vancomycin group

United States United Kingdom Mark Wilcox Kostenloser Wertpapierhandel Van Prehn Susi Teichmann

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Clinical Study Group News Today

Management of Clostridoides Difficile: A Focus on the Pharmacist's Role in the Care Continuum

Tillotts Pharma AG announces that DIFICLIRTM (fidaxomicin) is recommended for the treatment of Clostridioides difficile infection (CDI) by ESCMID

Explore More Categories